On Aug. 5, from 12– 1 p.m. ET, the NHC will host a member webinar on the proposed rule for the 2029 Medicare Drug Price Negotiation Program. The webinar will provide an overview of key proposed policy changes, including updates related to Qualifying Single Source Drugs (QSSDs), fixed combination products, small biotechnology products, and other negotiation eligible drugs, as well as a discussion of the potential implications for patients and the broader health care ecosystem.